|
WO2020178695A1
|
|
Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
|
|
WO2020115709A1
|
|
Modified release pharmaceutical composition
|
|
US2019282532A1
|
|
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
|
|
US10493051B1
|
|
Cysteine composition and injection
|
|
EP3727348A1
|
|
Packaged modified release gamma-hydroxybutyrate formulations having improved stability
|
|
UY37341A
|
|
FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS
|
|
USRE46686E
|
|
Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
|
|
US2015313846A1
|
|
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
BR122013000700B1
|
|
"suspension microcapsules in a net stage aquasa"
|
